Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Verheij

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 26, 2020
Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trialAstrid E Slagter, Benjamin Tudela, Romy M van Amelsfoort, et al.
The Lancet. Oncology|April 14, 2018
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trialAnnemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasetsTomas Skripcak, Claus Belka, Walter Bosch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitorsEvert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, et al.
BMC Cancer|September 12, 2018
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancerAstrid E Slagter, Edwin P M Jansen, Hanneke W M van Laarhoven, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 7, 2022
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trialsHedde D Biesma, Tanya T D Soeratram, Karolina Sikorska, et al.
Nature Communications|January 29, 2020
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancerAlessandro Leal, Nicole C T van Grieken, Doreen N Palsgrove, et al.
Nature|May 31, 2019
Genome-wide cell-free DNA fragmentation in patients with cancerStephen Cristiano, Alessandro Leal, Jillian Phallen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2022
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in EuropeTiuri E Kroese, Richard van Hillegersberg, Sebastian Schoppmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2023
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in EuropeTiuri E Kroese, Hanneke W M van Laarhoven, Sebastian F Schoppman, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|March 26, 2020
Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trialAstrid E Slagter, Benjamin Tudela, Romy M van Amelsfoort, et al.
The Lancet. Oncology|April 14, 2018
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trialAnnemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasetsTomas Skripcak, Claus Belka, Walter Bosch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2025
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitorsEvert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, et al.
BMC Cancer|September 12, 2018
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancerAstrid E Slagter, Edwin P M Jansen, Hanneke W M van Laarhoven, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 7, 2022
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trialsHedde D Biesma, Tanya T D Soeratram, Karolina Sikorska, et al.
Nature Communications|January 29, 2020
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancerAlessandro Leal, Nicole C T van Grieken, Doreen N Palsgrove, et al.
Nature|May 31, 2019
Genome-wide cell-free DNA fragmentation in patients with cancerStephen Cristiano, Alessandro Leal, Jillian Phallen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2022
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in EuropeTiuri E Kroese, Richard van Hillegersberg, Sebastian Schoppmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2023
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in EuropeTiuri E Kroese, Hanneke W M van Laarhoven, Sebastian F Schoppman, et al.
Pageof 19